Sort
48,018 grants matching “immunotherapy”
Human Mab Cocktails to Prevent & Treat H5N1 Avian Influenza
$1,378,013Wayne A. Marasco · Dana-Farber Cancer Inst · U01 · FY2008 · AI
Novel Strategies to Enhance Drug Delivery and Tumor Immunogenicity in Pancreatic Cancer
$1,377,000Bolni Marius Nagalo · Univ Of Arkansas For Med Scis · DP2 · FY2024 · CA
Novel approaches to cancer therapy
$1,376,721University Of Pennsylvania · P01 · FY2005 · CA
Advanced Technologies - National Center for Image Guided Therapy (AT-NCIGT)
$1,376,500Clare M Tempany · Brigham And Women'S Hospital · P41 · FY2025 · EB
Integrated Genomic and Functional Studies of Immunotherapy for Multi-Food Allergy
$1,375,860Stephen J Galli · Stanford University · U19 · FY2019 · AI
Integrated Genomic and Functional Studies of Immunotherapy for Multi-Food Allergy
$1,375,860Stephen J Galli · Stanford University · U19 · FY2020 · AI
Integrated Genomic and Functional Studies of Immunotherapy for Multi-Food Allergy
$1,375,860Stephen J Galli · Stanford University · U19 · FY2021 · AI
Integrated Genomic and Functional Studies of Immunotherapy for Multi-Food Allergy
$1,375,860Stephen J Galli · Stanford University · U19 · FY2023 · AI
Integrated Genomic and Functional Studies of Immunotherapy for Multi-Food Allergy
$1,375,860Stephen J Galli · Stanford University · U19 · FY2022 · AI
Programming T Cell Fates for Therapeutic Use
$1,374,247Luca Gattinoni · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Development of Therapeutic Antibody for Traumatic Brain Injury
$1,374,083Kun Ping Lu · Beth Israel Deaconess Medical Center · U01 · FY2017 · NS
Immunotherapy of low grade lymphoid malignancies
$1,371,922Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
IND-Enabling Toxicology for a Novel Ca2+ Channel Therapeutic to Improve Outcomes Associated with Checkpoint Inhibitor Immunotherapy
$1,371,030Milton L Greenberg · Vivreon Biosciences, Llc · R44 · FY2022 · CA
Resource for Molecular Imaging Agents in Precision Medicine
$1,368,554Martin G Pomper · Johns Hopkins University · P41 · FY2018 · EB
Improving the Outcome of Patients with Chronic Myeloid Leukemia Through Medi
$1,367,891Jorge E Cortes · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA
HAWAII ACTU - ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM
$1,367,841University Of Hawaii At Manoa · U01 · FY2002 · AI
Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes
$1,367,242Brigitte Widemann · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Pathogenesis and Treatment of Anaphylaxis
$1,366,986Melody C Carter · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
The Boston Lung Cancer Survival Cohort
$1,366,752David C Christiani · Harvard School Of Public Health · U01 · FY2020 · CA
CAR-T cell treatment of CNS Autoimmunity
$1,365,252Gregory Wu · Washington University · R01 · FY2025 · AI
Clinical Trials of Patients with AIDS-Related Malignancies
$1,365,193Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
International Research in Cambodia: Tropical Medicine and Vector Research
$1,364,178Christina Yek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Checkpoint inhibitor treatment for EBV+ lymphoma among HIV+ individuals
$1,364,053Mark Roschewski · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Novel Targets for Immunotherapy
$1,363,673Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA
Overcoming resistance to BRAF(V600E) targeted therapies in melanoma
$1,363,291David E Fisher · Massachusetts General Hospital · P01 · FY2014 · CA